THC Therapeutics Inc logo

THC Therapeutics Inc

$ 0.06 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 2.04M
Enterprise V:
$ 2.85M
Volume:
-
Avg Vol (2M):
13.11K
Volume:
-
Market Cap $:
2.04M
PE Ratio:
At Loss
Avg Vol (2-Month):
13.11K
Enterprise Value $:
2.85M
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -15.02
Debt-to-Equity -0.26
Debt-to-EBITDA -0.59
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 52.72
9-Day RSI 52.1
14-Day RSI 52.46
6-1 Month Momentum % 45.48
12-1 Month Momentum % -49.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.9

Profitability Rank

Name Current Vs Industry Vs History
ROA % -533.76
ROIC % -78.51
ROC (Joel Greenblatt) % -22129.03
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -2.08
EV-to-EBITDA -2.1
EV-to-FCF -6.61
Earnings Yield (Greenblatt) % -48.08

Financials

THCT's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:THCT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.05
Beta 0.41
Volatility % 3641.37
14-Day RSI 52.46
14-Day ATR ($) 0.014886
20-Day SMA ($) 0.05517
12-1 Month Momentum % -49.65
52-Week Range ($) 0.0002 - 0.195
Shares Outstanding (Mil) 34.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

THC Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

THC Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.